CERo Therapeutics Stock (NASDAQ:CEROW)
Previous Close
$0.01
52W Range
$0.02 - $0.02
50D Avg
$0.02
200D Avg
$0.02
Market Cap
$9.65M
Avg Vol (3M)
$119.03K
Beta
0.44
Div Yield
-
CEROW Company Profile
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.